Lipitor Users May Be 12% More Likely to Develop Diabetes, U.K. Study Finds
The makers of Lipitor and other statins have remained steadfast in their defense of the medications, even after a study led by British researchers dug up startling findings about their alleged link to diabetes.
The Telegraph reported on September 23rd that statin users were 12 percent more likely to develop diabetes over a four-year period, compared to those not taking the medication type. These individuals also gained around half a pound (240) in weight, according to researchers from University College London’s Institute of Cardiovascular Science. These findings were discovered after scientists analyzed data from 220,000 people, and results from nearly 130,000 patients who participated in earlier statin studies.
According to the Telegraph, these findings are published in the latest online edition of The Lancet medical journal, and “help to explain the mechanism by which statins increase weight and diabetes risk,” concludes the director of the UCL Institute. The information is valuable to “millions of Britons” who currently take Lipitor and other statins to lower their cholesterol, the article states.
Lipitor Lawsuits Allege Type 2 Diabetes Risk
It has yet to be determined whether this study will impact the mounting litigation involving Lipitor, a widely-used statin medication manufactured by Pfizer, Inc. As of September 2014, more than 1,200 lawsuits over the medication had been filed in a federal multidistrict litigation (MDL) underway in the U.S. District Court, District of South Carolina. Plaintiffs in these cases similarly allege that Pfizer failed to adequately warn patients about the risk for statin injuries, including new-onset diabetes. They further allege that Lipitor’s association with the disease is not properly displayed on its labeling, even after it was adjusted in February 2012 at an order from the U.S. Food and Drug Administration (FDA).
The FDA issued this mandate after research from JAMA: Internal Medicine published findings of a study that revealed an increased risk for the disease in women taking Lipitor.
This and other statins work by reducing the efficiency of an enzyme that causes liver cells to collect more low-density lipopretin (LDL), keeping it away from the blood stream.
Did You Develop Diabetes after Taking Lipitor? Call Us Today.
Contact our Firm for more about the association between Lipitor and diabetes at (877) 779-1414. You may be eligible to file a claim against its manufacturer, Pfizer Inc.